Home/Filings/4/0001765581-22-000021
4//SEC Filing

Larkin Finbar 4

Accession 0001765581-22-000021

CIK 0001232524other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 5:56 PM ET

Size

5.2 KB

Accession

0001765581-22-000021

Insider Transaction Report

Form 4
Period: 2022-03-03
Larkin Finbar
SVP, Technical Development
Transactions
  • Award

    Ordinary Shares

    2022-03-03+4,62121,209 total
Footnotes (2)
  • [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
  • [F2]Includes 120 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001793243

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:56 PM ET
Size
5.2 KB